Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer

Abstract Background BRCA‐associated breast cancers tend to have distinctive features compared to sporadic breast cancers; further characterization can aid in optimizing treatment. Methods The study evaluated a patient cohort with early‐stage estrogen receptor positive, HER2 negative invasive breast...

Full description

Bibliographic Details
Main Authors: Rachel M. Layman, Heather Lin, Angelica M. Gutierrez Barrera, Meghan S. Karuturi, Clinton Yam, Banu K. Arun
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Cancer Medicine
Subjects:
BRCA1
BRCA2
breast cancer
estrogen receptor
gene expression profiling
survival analysis
Online Access:https://doi.org/10.1002/cam4.4566

Internet

https://doi.org/10.1002/cam4.4566

Similar Items